Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Hai-Peng Xi"'
Publikováno v:
International Journal of Neuroscience. 131:1162-1172
Ischemic stroke (IS) is a major public health issue causing mortality and disability and is more difficult to treat than other cerebral diseases. Previous study reported that miR-376a was upregulat...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b81e12d2c0626fc25acf4fbb84be3eca
https://doi.org/10.1080/00207454.2020.1782904
https://doi.org/10.1080/00207454.2020.1782904
Publikováno v:
The International journal of neuroscience. 131(12)
Ischemic stroke (IS) is a major public health issue causing mortality and disability and is more difficult to treat than other cerebral diseases. Previous study reported that miR-376a was upregulated in the serum of stroke patients, indicating that m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::dd343cd4145dac273ed93a0768d5493a
https://pubmed.ncbi.nlm.nih.gov/32532171
https://pubmed.ncbi.nlm.nih.gov/32532171
Publikováno v:
International immunopharmacology. 83
Background Dendritic cell (DC)-based vaccination has been suggested to be promising for glioblastoma. However, the evidence in randomized controlled trials (RCTs) is inconsistent. We aimed to systematically evaluate the efficacy and safety of DC vacc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f91e152a4b6cec809b0d0160d38a9583
https://pubmed.ncbi.nlm.nih.gov/32213460
https://pubmed.ncbi.nlm.nih.gov/32213460
Publikováno v:
Genomics. 112(1)
Glioma is one of the most common and aggressive malignant primary brain tumor with invariably poor 5-year survival rates. Because of the high recurrence rate and mortality rate, effective therapies for glioma are still weak. Recently, several studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f539d21266f976220e5627ec5686d2fd
https://pubmed.ncbi.nlm.nih.gov/31226483
https://pubmed.ncbi.nlm.nih.gov/31226483
Publikováno v:
Cardiovascular Diabetology, Vol 17, Iss 1, Pp 1-10 (2018)
Abstract Background Cardiovascular (CV) safety of one anti-diabetic medication over another remains partially delineated. We sought to assess the comparative effect on CV outcomes among novel anti-diabetic agents. Methods This study was registered wi
Externí odkaz:
https://doaj.org/article/a23b181aca4b4db9bf8f0fd743f38917
Publikováno v:
PLoS ONE, Vol 12, Iss 3, p e0173576 (2017)
Liraglutide is administered as glucagon-like peptide-1 (GLP-1) receptor agonist for diabetic patients and can protect pancreatic β-cells by inhibiting their apoptosis. MicroRNA-139-5p (miRNA-139-5p) participates in the regulation of cancer cell apop
Externí odkaz:
https://doaj.org/article/7b4a226146c74bf8a7d373c49d869df7
Autor:
Ying-ying Gong, Yuan-yuan Liu, Jin Li, Lei Su, Shuang Yu, Xiao-nan Zhu, Xiao-pei Cao, Hai-peng Xiao
Publikováno v:
PLoS ONE, Vol 9, Iss 12, p e113784 (2014)
High-fat diet (HFD) is an environmental factor that contributes to the pathogenesis of obesity and type 2 diabetes. A number of genes influencing oxidative phosphorylation (OXPHOS) were found to be downregulated in skeletal muscle of humans and rats
Externí odkaz:
https://doaj.org/article/c8e3c8f2d953433a84c21699f83e5e70